Biotech Investments Fueling the Gene Expression Analysis Market Growth
The Gene Expression Analysis Market is witnessing accelerated growth due to increasing investments by biotechnology firms. Companies are expanding R&D in genomics, creating innovative platforms for gene profiling and biomarker discovery.
Government grants and private venture capital are further supporting research initiatives, allowing the development of high-throughput sequencing technologies. These investments are enhancing market capacity and increasing adoption in both research and clinical settings.
Market Outlook: Valued at USD 4.74 billion in 2024, the market is expected to reach USD 12.67 billion by 2034, growing at a 10.32% CAGR.